









市場行情
/
股票
/
nasdaq-htfl
/

Heartflow Inc

HTFL

31.580USD

+1.070+3.51%

交易中（美東）報價延遲15分鐘

2.64B總市值

虧損本益比TTM



Heartflow Inc

31.580

+1.070+3.51%

概覽公司財務分析

概覽

公司

財務

分析

關於 Heartflow Inc 公司

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc簡介



公司代碼HTFL

公司名稱Heartflow Inc

上市日期Aug 08, 2025

CEOFarquhar (John C. M)

員工數量699

證券類型Ordinary Share

年結日Aug 08

公司地址331 E Evelyn Avenue

城市MOUNTAIN VIEW

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編94041

電話16502411221

網址https://www.heartflow.com/

公司代碼HTFL

上市日期Aug 08, 2025

CEOFarquhar (John C. M)

Heartflow Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Vikram Verghese

Chief Financial Officer

123.86K

-0.38%

Mr. Lonnie M. Smith

Independent Director

34.25K

Mr. Casey M. Tansey

Independent Director

16.45K

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

Mr. Tim Barabe

Independent Director

Ms. Julie Cullivan

Independent Director

Mr. Jeffrey C. Lightcap

Independent Director

Mr. William C. (Bill) Weldon

Independent Chairman of the Board

Dr. Wayne Riley, M.D.

Independent Director

Dr. Nicholas Downing, M.D.

Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Vikram Verghese

Chief Financial Officer

123.86K

-0.38%

Mr. Lonnie M. Smith

Independent Director

34.25K

Mr. Casey M. Tansey

Independent Director

16.45K

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

Mr. Tim Barabe

Independent Director

Ms. Julie Cullivan

Independent Director

收入明細

由於公司未披露，未能獲取相關數據

由於公司未披露，未能獲取相關數據

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月30日週日

持股股東

股東類型

持股股東

佔比

Bain Capital Life Sciences Investors, LLC

14.62%

HealthCor Partners Management LP

7.86%

Wellington Management Company, LLP

5.73%

Fidelity Management & Research Company LLC

5.42%

Capricorn Investment Group LLC

4.61%

其他

61.76%

持股股東

佔比

Bain Capital Life Sciences Investors, LLC

14.62%

HealthCor Partners Management LP

7.86%

Wellington Management Company, LLP

5.73%

Fidelity Management & Research Company LLC

5.42%

Capricorn Investment Group LLC

4.61%

其他

61.76%

股東類型

持股股東

佔比

Investment Advisor

53.56%

Investment Advisor/Hedge Fund

12.32%

Hedge Fund

3.14%

Individual Investor

2.47%

Endowment Fund

0.37%

Private Equity

0.18%

Pension Fund

0.14%

Research Firm

0.10%

Bank and Trust

0.08%

其他

27.65%

機構持股



更新時間: 9月12日週五

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

45.42M

54.46%

+42.91M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Bain Capital Life Sciences Investors, LLC

12.45M

14.93%

+12.45M

Aug 08, 2025

HealthCor Partners Management LP

6.70M

8.03%

+6.70M

Aug 08, 2025

Wellington Management Company, LLP

4.41M

5.29%

+4.41M

Aug 08, 2025

Fidelity Management & Research Company LLC

3.29M

3.94%

+3.29M

Aug 08, 2025

Capricorn Investment Group LLC

3.92M

4.7%

+3.92M

Aug 08, 2025

Hayfin Capital Management LLP

3.64M

4.36%

+3.64M

Aug 08, 2025

The Vanguard Group, Inc.

1.17M

1.4%

+1.17M

Aug 31, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

TrueShares Technology, AI & Deep Learning ETF

3.13%

Global X HealthTech ETF

1.75%

Fidelity Blue Chip Growth ETF

0.07%

T Rowe Price Small-Mid Cap ETF

0.06%

iShares Health Innovation Active ETF

0.02%

Schwab U.S. Small-Cap ETF

0.02%

Fidelity Nasdaq Composite Index ETF

0.01%

Schwab U.S. Broad Market ETF

TrueShares Technology, AI & Deep Learning ETF

佔比3.13%

Global X HealthTech ETF

佔比1.75%

Fidelity Blue Chip Growth ETF

佔比0.07%

T Rowe Price Small-Mid Cap ETF

佔比0.06%

iShares Health Innovation Active ETF

佔比0.02%

Schwab U.S. Small-Cap ETF

佔比0.02%

Fidelity Nasdaq Composite Index ETF

佔比0.01%

Schwab U.S. Broad Market ETF

佔比0%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Heartflow Inc的前五大股東是誰？



Heartflow Inc的前五大股東如下：
Bain Capital Life Sciences Investors, LLC
持有股份：12.45M
佔總股份比例：14.93%。
HealthCor Partners Management LP
持有股份：6.70M
佔總股份比例：8.03%。
Wellington Management Company, LLP
持有股份：4.41M
佔總股份比例：5.29%。
Fidelity Management & Research Company LLC
持有股份：3.29M
佔總股份比例：3.94%。
Capricorn Investment Group LLC
持有股份：3.92M
佔總股份比例：4.70%。